5:00 pm
Translating biomedical discoveries into real-world applications is essential to improving human health. It’s a complex process that can result in delays of years or decades before improved patient outcomes result from discoveries in biomedical research – and...
12:00 am
CHeSS, an ITM partner, is accepting applications for its Summer Program in Outcomes Research Training (SPORT) program, which provides an introduction to outcomes research for fellows and junior faculty, including coursework in health services research,...
5:00 pm
The University of Chicago Medicine (UCM) and the Institute for Translational Medicine (ITM) are committed to improving the health of residents on the South Side of Chicago. As part of this commitment, UCM and ITM...
12:00 am
The NIH’s Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) provide up to $1 million over two years for small businesses and research organizations whose work in any biomedical or behavioral research area...
12:00 am
This funding opportunity accepts applications for a Clinical and Translational Science Award (CTSA) Program Data to Health Coordination Center that will support the activities of the CTSA Program in using data to translate discoveries to health...
12:00 am
NCATS will fund up to $400,000 for projects that develop 3D-bioprinted tissue models for drug discovery, including efficacy studies and toxicology research through a collaborative arrangement between the 3-D Bioprinting Program at NCATS and other scientists....
12:00 am
The NIH-Industry Program: Discovering New Therapeutic Uses for Existing Molecules program supports partnerships between pharmaceutical companies and the biomedical research community to advance therapeutics development. This innovative program matches researchers with pharmaceutical industry resources to test...
12:00 am
Access Pfizer’s drug development expertise, publishing rights and its Centers for Therapeutic Innovation (CTI) foundation partners through research. The CTI and NIH are now accepting proposals for collaborative projects that focus on translational therapeutic drug...
5:00 pm
The NIH’s National Cancer Institute (the NIH is the parent organization of the ITM) will fund $4 million to approximately 10 exploratory projects that develop or validate emerging technologies that contribute to targeting, probing, or...
5:00 pm
The NIH’s National Cancer Institute (the NIH is the parent organization of the ITM) will fund $4 million to approximately 10 exploratory projects focused on the inception and early-stage development of innovative molecular and cellular...
1:26 pm
Apply for your chance at: up to $60,000 for your research access to the ITM’s resources and network to make your project happen a video highlighting your findings
5:00 pm
The Sharing Partnership for Innovative Research in Translation (SPIRiT), a CTSA consortium, has a new funding program in part funded by the ITM that supports pilot research projects between investigators from SPIRiT sites, including Johns Hopkins...
5:00 pm
The National Institute of Mental Health will fund up to $1.75 million per year for applications for Silvio O. Conte Centers for Basic Neuroscience or Translational Mental Health Research. The institute seeks teams of researchers employing...
12:00 am
UChicago students, faculty, staff and alums can apply for the chance to win $10,000 to build an app. Submit your good idea, and UChicago, in partnership with IT Services and the Polsky Center, will do...
5:00 pm
The National Cancer Institute will award $400,000 per year for up to five years for projects that develop state-of-the-art biomimetic tissue-engineered technologies for cancer research. Collaborative, multidisciplinary projects that engage the fields of regenerative medicine, tissue...
5:00 pm
NIH’s, the ITM’s parent organization, National Institute on Aging and National Cancer Institute will fund research projects that increase our understanding of the clinical translational potential of metformin to delay aging changes or to extend healthy...
5:00 pm
The NIH’s National Institute on Aging will award $40,000 per year to applications from qualified researchers to acquire training and career development experiences that close expertise gaps in data science and in drug discovery. The goal...
5:00 pm
Translating biomedical discoveries into real-world applications is essential to improving human health. It’s a complex process that can result in delays of years or decades before improved patient outcomes result from discoveries in biomedical research – and...
12:00 am
NCATS will fund up to $500,000 per year for projects that support testing new therapeutic uses for experimental drugs across a broad range of pediatric diseases. This innovative program allows investigators to propose new therapeutic uses for...
5:00 pm
The NIH’s National Cancer Institute (the NIH is the parent organization of the ITM) will fund $4 million to approximately 10 exploratory projects that develop or validate emerging technologies that contribute to targeting, probing, or...
5:00 pm
The NIH’s National Cancer Institute (the NIH is the parent organization of the ITM) will fund $4 million to approximately 10 exploratory projects focused on the inception and early-stage development of innovative molecular and cellular...
12:00 am
PhRMA Foundation will award $100,000 to research related to healthcare delivery, including evaluating the design, delivery and effectiveness of pharmaceuticals. Projects rooted in a variety of backgrounds and topics are encouraged to apply, including pharmacoeconomics and patient-reported...
12:00 am
PhRMA Foundation will award $40,000 to postdoctoral researchers whose research will develop and use informatics to help understand human biological and disease processes and that significantly integrate state-of-the-art information technology with advanced biological, chemical and pharmacological sciences. Learn more and apply...
12:00 am
PhRMA Foundation will award $20,000 to research projects that develop and use informatics to help understand human biological and disease processes and that significantly integrate state-of-the-art information technology with advanced biological, chemical, and pharmacological sciences. Learn more and apply...
12:00 am
PhRMA Foundation will award $100,000 to research that will develop and use informatics to help understand human biological and disease processes and that significantly integrates state-of-the-art information technology with advanced biological, chemical and pharmacological sciences.Learn more and apply for...
12:00 am
PhRMA Foundation will award $40,000 to mid-career scientists whose research will develop and use informatics to help understand human biological and disease processes and that significantly integrate state-of-the-art information technology with advanced biological, chemical and pharmacological sciences. Learn more...
12:00 am
PhRMA Foundation will award $40,000 to postdoctoral researchers whose research will deal with drug delivery systems, especially the design and evaluation of pharmaceutical dosage forms and systems to ensure their safety, efficacy and reliability. Pharmaceutics strongly emphasizes quantitative understanding...
12:00 am
PhRMA Foundation will award $20,000 to research that deals with drug delivery systems, especially the design and evaluation of pharmaceutical dosage forms and systems to ensure their safety, efficacy and reliability. Pharmaceutics strongly emphasizes quantitative understanding of the...
12:00 am
PhRMA Foundation will award $100,000 to research that will deal with drug delivery systems, especially the design and evaluation of pharmaceutical dosage forms and systems to ensure their safety, efficacy and reliability. Pharmaceutics strongly emphasizes quantitative understanding of...
12:00 am
PhRMA Foundation will award $40,000 to mid-career scientists whose research will deal with drug delivery systems, especially the design and evaluation of pharmaceutical dosage forms and systems to ensure their safety, efficacy and reliability. Pharmaceutics strongly emphasizes quantitative...
Mar
29
Wed
DEADLINE: Exploratory CTSA Collaborative Innovation Awards (R21) Application
Mar 29 @ 5:00 pm
DEADLINE: Exploratory CTSA Collaborative Innovation Awards (R21) Application

Translating biomedical discoveries into real-world applications is essential to improving human health. It’s a complex process that can result in delays of years or decades before improved patient outcomes result from discoveries in biomedical research – and NCATS wants solutions. NCATS’ (the ITM’s parent organization) spurs the development, demonstration, and dissemination of innovations across the translational science spectrum to turn discoveries from the laboratory into tangible benefits to human health. NCATS’s Clinical and Translational Science Award (CTSA) hubs, like the ITM, promote advances in translational research and training at participating institutions.

This funding opportunity funds up to $275,000 to new exploratory and developmental research projects. These studies may involve considerable risk but may lead to a breakthrough in a particular area, or to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on translational science. This grant will enable collaborative teams of investigators from at least two different CTSA institutions to address translational science questions. Collaborations that bring together approaches from different scientific disciplines are encouraged.

Learn more and submit your application here.

Source: NCATS

Mar
30
Thu
DEADLINE: Summer Program in Outcomes Research Training (SPORT) Application
Mar 30 all-day
DEADLINE: Summer Program in Outcomes Research Training (SPORT) Application

CHeSS, an ITM partner, is accepting applications for its Summer Program in Outcomes Research Training (SPORT) program, which provides an introduction to outcomes research for fellows and junior faculty, including coursework in health services research, biostatistics, research methods, and clinical epidemiology. The program also offers participants opportunities to develop a research proposal that could form the basis of an NIH or other career development award, and several SPORT courses are led by ITM investigators. Earn up to $3,000 to participate in SPORT.

2017 Program Dates: July 10 – Aug. 25, 2017

Learn more and register for the program here. 

Source: CHeSS

Apr
3
Mon
DEADLINE: Adult Breast and Colorectal Cancer Proposals
Apr 3 @ 5:00 pm
DEADLINE: Adult Breast and Colorectal Cancer Proposals
The University of Chicago Medicine (UCM) and the Institute for Translational Medicine (ITM) are committed to improving the health of residents on the South Side of Chicago. As part of this commitment, UCM and ITM are sponsoring a joint grant initiative designed for the community benefit program that extends financial support to local nonprofits to provide health-related services and programming to at-risk and underserved populations aligned with our strategic health priorities.
This new round of funding will provide up to $50,000 to projects that focus on Adult Breast and Colorectal Cancer. Applicants will partner with a UCM Research Collaborator to help execute the project, evaluate its impact and disseminate its results. ITM and UCM are happy to provide those introductions.
Apr
5
Wed
DEADLINE: Small Business Innovation Research & Small Business Technology Transfer Grant Applications
Apr 5 all-day
DEADLINE: Small Business Innovation Research & Small Business Technology Transfer Grant Applications

The NIH’s Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) provide up to $1 million over two years for small businesses and research organizations whose work in any biomedical or behavioral research area falls within the NIH’s mission to improve human health. NCATS small business funding is designed specifically to transform the translational science process so that new treatments and cures for disease can be delivered to patients more efficiently.

Learn more and apply here.

Source: NIH

Apr
14
Fri
DEADLINE: CTSA Program Data to Health (CD2H) Coordinating Center Application
Apr 14 all-day
DEADLINE: CTSA Program Data to Health (CD2H) Coordinating Center Application

This funding opportunity accepts applications for a Clinical and Translational Science Award (CTSA) Program Data to Health Coordination Center that will support the activities of the CTSA Program in using data to translate discoveries to health benefit. It will provide up to $5 million over five years for projects that discover, develop, and disseminate innovation in informatics tools, standards, methods, and processes that will eventually benefit human health.

Learn more and apply here.

Source: NIH NCATS

DEADLINE: NCATS Pilot Program for Collaborative Drug Discovery Research using Bioprinted Skin Tissue Application
Apr 14 all-day
DEADLINE: NCATS Pilot Program for Collaborative Drug Discovery Research using Bioprinted Skin Tissue Application

NCATS will fund up to $400,000 for projects that develop 3D-bioprinted tissue models for drug discovery, including efficacy studies and toxicology research through a collaborative arrangement between the 3-D Bioprinting Program at NCATS and other scientists.

NCATS scientists will provide expertise for 3-D bioprinting, assay development, and drug screening stages of the projects. Other investigators will provide appropriate cell resources, disease expertise, and model validation to perform drug screening of bioprinted materials.

Learn more and submit your application here.

Source: NIH NCATS

Apr
17
Mon
DEADLINE: Discovering New Therapeutic Uses for Existing Molecules Pre-Application
Apr 17 all-day
DEADLINE: Discovering New Therapeutic Uses for Existing Molecules Pre-Application

The NIH-Industry Program: Discovering New Therapeutic Uses for Existing Molecules program supports partnerships between pharmaceutical companies and the biomedical research community to advance therapeutics development. This innovative program matches researchers with pharmaceutical industry resources to test ideas for new therapeutic uses with the ultimate goal of identifying promising new treatments for patients.

Learn more and apply here.

Source: NIH

Apr
21
Fri
DEADLINE: Pfizer’s Centers for Therapeutic Innovation for NIH Researchers Proposals
Apr 21 all-day

Access Pfizer’s drug development expertise, publishing rights and its Centers for Therapeutic Innovation (CTI) foundation partners through research. The CTI and NIH are now accepting proposals for collaborative projects that focus on translational therapeutic drug targets.

Pfizer’s CTI pairs NIH intramural researchers with Pfizer scientists to pursue scientific and medical advances through joint research and development projects. The CTI model is the first NIH-wide biologics initiative with a pharmaceutical partner that NCATS coordinates on behalf of all NIH intramural researchers. The goal of the program is to identify biologic compounds with activity in a pathway or target of interest to an NIH intramural researcher and to Pfizer. Together, the scientific team works to move these compounds through laboratory testing and into clinical evaluation.

Source: NCATS
Apr
26
Wed
DEADLINE: Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research Letter of Intent
Apr 26 @ 5:00 pm
DEADLINE: Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research Letter of Intent

The NIH’s National Cancer Institute (the NIH is the parent organization of the ITM) will fund $4 million to approximately 10 exploratory projects that develop or validate emerging technologies that contribute to targeting, probing, or assessing molecular and cellular features of cancer biology. Projects should show potential to improve cancer biology research, early detection and screening, clinical diagnosis, treatment, control, epidemiology, and/or address issues associated with cancer health disparities.

Learn more and submit your Letter of Intent.

Source: National Cancer Institute

DEADLINE: Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research Letter of Intent
Apr 26 @ 5:00 pm
DEADLINE: Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research Letter of Intent

The NIH’s National Cancer Institute (the NIH is the parent organization of the ITM) will fund $4 million to approximately 10 exploratory projects focused on the inception and early-stage development of innovative molecular and cellular analysis technologies. Projects should show potential to improve cancer biology research, early detection and screening, clinical diagnosis, treatment, control, epidemiology, and/or address issues associated with cancer health disparities.

Learn more and submit your Letter of Intent.

Source: National Cancer Institute